362 related articles for article (PubMed ID: 20952512)
1. RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer.
Somyajit K; Subramanya S; Nagaraju G
Carcinogenesis; 2010 Dec; 31(12):2031-8. PubMed ID: 20952512
[TBL] [Abstract][Full Text] [Related]
2. Distinct roles of FANCO/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility.
Somyajit K; Subramanya S; Nagaraju G
J Biol Chem; 2012 Jan; 287(5):3366-80. PubMed ID: 22167183
[TBL] [Abstract][Full Text] [Related]
3. Fanconi anemia and breast cancer susceptibility meet again.
Levy-Lahad E
Nat Genet; 2010 May; 42(5):368-9. PubMed ID: 20428093
[TBL] [Abstract][Full Text] [Related]
4. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.
Meindl A; Hellebrand H; Wiek C; Erven V; Wappenschmidt B; Niederacher D; Freund M; Lichtner P; Hartmann L; Schaal H; Ramser J; Honisch E; Kubisch C; Wichmann HE; Kast K; Deissler H; Engel C; Müller-Myhsok B; Neveling K; Kiechle M; Mathew CG; Schindler D; Schmutzler RK; Hanenberg H
Nat Genet; 2010 May; 42(5):410-4. PubMed ID: 20400964
[TBL] [Abstract][Full Text] [Related]
5. Mutation of the RAD51C gene in a Fanconi anemia-like disorder.
Vaz F; Hanenberg H; Schuster B; Barker K; Wiek C; Erven V; Neveling K; Endt D; Kesterton I; Autore F; Fraternali F; Freund M; Hartmann L; Grimwade D; Roberts RG; Schaal H; Mohammed S; Rahman N; Schindler D; Mathew CG
Nat Genet; 2010 May; 42(5):406-9. PubMed ID: 20400963
[TBL] [Abstract][Full Text] [Related]
6. Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan.
Rashid MU; Muhammad N; Faisal S; Amin A; Hamann U
Breast Cancer Res Treat; 2014 Jun; 145(3):775-84. PubMed ID: 24800917
[TBL] [Abstract][Full Text] [Related]
7. Germline RAD51C mutations in ovarian cancer susceptibility.
Coulet F; Fajac A; Colas C; Eyries M; Dion-Minière A; Rouzier R; Uzan S; Lefranc JP; Carbonnel M; Cornelis F; Cortez A; Soubrier F
Clin Genet; 2013 Apr; 83(4):332-6. PubMed ID: 22725699
[TBL] [Abstract][Full Text] [Related]
8. Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility.
Vuorela M; Pylkäs K; Hartikainen JM; Sundfeldt K; Lindblom A; von Wachenfeldt Wäppling A; Haanpää M; Puistola U; Rosengren A; Anttila M; Kosma VM; Mannermaa A; Winqvist R
Breast Cancer Res Treat; 2011 Dec; 130(3):1003-10. PubMed ID: 21750962
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer and Fanconi anemia: what are the connections?
Zdzienicka MZ; Arwert F
Trends Mol Med; 2002 Oct; 8(10):458-60. PubMed ID: 12383764
[TBL] [Abstract][Full Text] [Related]
10. Germline mutation in the RAD51B gene confers predisposition to breast cancer.
Golmard L; Caux-Moncoutier V; Davy G; Al Ageeli E; Poirot B; Tirapo C; Michaux D; Barbaroux C; d'Enghien CD; Nicolas A; Castéra L; Sastre-Garau X; Stern MH; Houdayer C; Stoppa-Lyonnet D
BMC Cancer; 2013 Oct; 13():484. PubMed ID: 24139550
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of germline RAD51C missense variants highlight the role of RAD51C in replication fork protection.
Kolinjivadi AM; Chong ST; Choudhary R; Sankar H; Chew EL; Yeo C; Chan SH; Ngeow J
Hum Mol Genet; 2023 Apr; 32(8):1401-1409. PubMed ID: 36562461
[TBL] [Abstract][Full Text] [Related]
12. RAD51C germline mutations found in Spanish site-specific breast cancer and breast-ovarian cancer families.
Blanco A; Gutiérrez-Enríquez S; Santamariña M; Montalban G; Bonache S; Balmaña J; Carracedo A; Diez O; Vega A
Breast Cancer Res Treat; 2014 Aug; 147(1):133-43. PubMed ID: 25086635
[TBL] [Abstract][Full Text] [Related]
13. Estrogen induces RAD51C expression and localization to sites of DNA damage.
Alayev A; Salamon RS; Manna S; Schwartz NS; Berman AY; Holz MK
Cell Cycle; 2016 Dec; 15(23):3230-3239. PubMed ID: 27753535
[TBL] [Abstract][Full Text] [Related]
14. Homologous recombination-deficient mutation cluster in tumor suppressor
Prakash R; Rawal Y; Sullivan MR; Grundy MK; Bret H; Mihalevic MJ; Rein HL; Baird JM; Darrah K; Zhang F; Wang R; Traina TA; Radke MR; Kaufmann SH; Swisher EM; Guérois R; Modesti M; Sung P; Jasin M; Bernstein KA
Proc Natl Acad Sci U S A; 2022 Sep; 119(38):e2202727119. PubMed ID: 36099300
[TBL] [Abstract][Full Text] [Related]
15. Mammalian RAD51 paralogs protect nascent DNA at stalled forks and mediate replication restart.
Somyajit K; Saxena S; Babu S; Mishra A; Nagaraju G
Nucleic Acids Res; 2015 Nov; 43(20):9835-55. PubMed ID: 26354865
[TBL] [Abstract][Full Text] [Related]
16. RAD51 paralogs: Expanding roles in replication stress responses and repair.
Bhattacharya D; Sahoo S; Nagraj T; Dixit S; Dwivedi HK; Nagaraju G
Curr Opin Pharmacol; 2022 Dec; 67():102313. PubMed ID: 36343481
[TBL] [Abstract][Full Text] [Related]
17. Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer.
Zheng Y; Zhang J; Hope K; Niu Q; Huo D; Olopade OI
Breast Cancer Res Treat; 2010 Dec; 124(3):857-61. PubMed ID: 20697805
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of RAD51L1 (RAD51B/REC2) in multiple-case, non-BRCA1/2 breast cancer families.
Johnson J; Healey S; Khanna KK; ; Chenevix-Trench G
Breast Cancer Res Treat; 2011 Aug; 129(1):255-63. PubMed ID: 21533530
[TBL] [Abstract][Full Text] [Related]
19. Interplay between human DNA repair proteins at a unique double-strand break in vivo.
Rodrigue A; Lafrance M; Gauthier MC; McDonald D; Hendzel M; West SC; Jasin M; Masson JY
EMBO J; 2006 Jan; 25(1):222-31. PubMed ID: 16395335
[TBL] [Abstract][Full Text] [Related]
20. RAD51C facilitates checkpoint signaling by promoting CHK2 phosphorylation.
Badie S; Liao C; Thanasoula M; Barber P; Hill MA; Tarsounas M
J Cell Biol; 2009 May; 185(4):587-600. PubMed ID: 19451272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]